Show simple item record

dc.contributor.authorAbed, Howraa
dc.contributor.authorBall, Patrick
dc.contributor.authorMorrissey, Hana
dc.date.accessioned2018-02-01T15:04:31Z
dc.date.available2018-02-01T15:04:31Z
dc.date.issued2017-11-30
dc.identifier.citationAbed, H., Ball, P., Morrissey, H., (2017) 'Pharmacists’ essential knowledge on cognitive impairment in the elderly population' International Journal of Current Research, 9 (11), pp. 1-7.
dc.identifier.issn0975-833X
dc.identifier.urihttp://hdl.handle.net/2436/621070
dc.description.abstractBackground: There are various factors which can lead to irreversible, reversible cognitive impairments. The progression of reversible cognitive disorders can be halted by identifying and treating the underlying cause. Aim of the Review: To expand pharmacists’ knowledge on underlying causes of cognitive impairment and investigate the possibility of pharmacist involvement in the identification of and/or protection against cognitive impairment. Method: A search of the literature was conducted through databases to identify studies in the English language of 1975-2016. Peer-reviewed articles and informational websites were included. Results: There are two broad classifications of cognitive impairment, irreversible and reversible cognitive impairment. Pharmacists can play an essential role in early detection of cognitive impairment caused by medications. Conclusion: Pharmacists have the potential to lead early detection of cognitive impairment caused by medications through appropriate management of the underlying problem. This may contribute to patients’ better health outcomes and quality of life.
dc.language.isoen
dc.publisherInternational journal of current research
dc.relation.urlhttp://www.journalcra.com/article/pharmacists%E2%80%99-essential-knowledge-cognitive-impairment-elderly-population
dc.subjectAnticholinergic burden
dc.subjectCauses of cognitive impairment
dc.subjectHome medication review
dc.titlePharmacists’ essential knowledge on cognitive impairment in the elderly population
dc.typeJournal article
dc.identifier.journalInternational Journal of Current Research
dc.date.accepted2017-11-01
rioxxterms.funderUniversity of Wolverhampton
rioxxterms.identifier.projectUoW010218HM
rioxxterms.versionAM
rioxxterms.licenseref.urihttps://creativecommons.org/CC BY-NC-ND 4.0
rioxxterms.licenseref.startdate2018--02-01
dc.source.volume9
dc.source.issue12
dc.source.beginpage62842
dc.source.endpage62848
refterms.dateFCD2018-10-19T09:26:31Z
refterms.versionFCDAM
refterms.dateFOA2018-08-21T14:46:35Z
html.description.abstractBackground: There are various factors which can lead to irreversible, reversible cognitive impairments. The progression of reversible cognitive disorders can be halted by identifying and treating the underlying cause. Aim of the Review: To expand pharmacists’ knowledge on underlying causes of cognitive impairment and investigate the possibility of pharmacist involvement in the identification of and/or protection against cognitive impairment. Method: A search of the literature was conducted through databases to identify studies in the English language of 1975-2016. Peer-reviewed articles and informational websites were included. Results: There are two broad classifications of cognitive impairment, irreversible and reversible cognitive impairment. Pharmacists can play an essential role in early detection of cognitive impairment caused by medications. Conclusion: Pharmacists have the potential to lead early detection of cognitive impairment caused by medications through appropriate management of the underlying problem. This may contribute to patients’ better health outcomes and quality of life.


Files in this item

Thumbnail
Name:
27891.pdf
Size:
270.6Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/CC BY-NC-ND 4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/CC BY-NC-ND 4.0